NOS2 and septic shock: Systemic administration of non-selective NOS inhibitors NG-methyl-l-arginine (L-NMMA) has been shown to reduce plasma nitrite and nitrate and increase systemic vascular resistance and blood pressure in humans with septic shock; it did not however improve mortality in patients with septic shock [2], [13], [18].